Jason Rickard - Aug 15, 2022 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
SVP, Chief Operating Officer
Signature
/s/ Ronald Silver, Attorney-in-Fact
Stock symbol
IRWD
Transactions as of
Aug 15, 2022
Transactions value $
-$11,699
Form type
4
Date filed
8/17/2022, 04:05 PM
Previous filing
Aug 10, 2022
Next filing
Dec 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Sale -$11.7K -994 -0.26% $11.77 376K Aug 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on September 4, 2018.